Due to China's huge consumer groups and the active support of the government, China's medical device market has a broad space for development. As the incidence of cancer increases year by year, nearly 70% of cancer patients need different levels of radiation therapy, and with the future of radiotherapy technology The further development of the policy, as well as the substantive implementation of policies such as the relaxation of major medical insurance, China's radiological medical market will show an accelerated growth. The Prospective Industry Research Institute predicts that the compound growth rate of the radiology medical industry is expected to remain at 25% to 30% in the next three to five years. Although China's medical device industry has developed rapidly after more than ten years, the situation of small and medium-sized enterprises in the industry has not changed. Low, small and scattered are one of the important characteristics of China's medical device industry. The development of the industry still needs to rely on production technology. Continue to innovate and develop. At present, China's fastener manufacturing enterprises have a large gap in production technology, equipment level, production technology and other aspects compared with foreign countries. A large number of small enterprises in the industry mainly produce low-end products. Even in large-scale enterprises in China, product quality and performance lag behind developed countries in Europe and America. Data show that in 2015, there were about 4.292 million new cancer cases and 2.814 million cancer deaths in China. According to statistics from the National Cancer Registry, there were 3.372 million new cancer cases in 2014, and about 2.2 million cancer deaths in China in 2012, showing an increasing trend year by year. It is worth noting that according to medical statistics, 80%-90% of early cancers can be cured. According to the China Cancer Registry Database, about 60% of cancer deaths in China can be prevented and avoided, which is higher than 30%-40% in developed countries. Therefore, PET/CT diagnosis as an important means, early diagnosis based on hospitals, physical examination centers and third-party imaging centers will become the main path of cancer prevention and control in China, and there is huge room for future development. According to the Prospective Industry Research Institute's "2016-2021 China Medical Device Industry Market Preview and Investment Forecast Analysis Report", there is a big gap between China's radiology field and mature foreign markets. The more developed the economy and the more advanced the medical concept, the higher the proportion of patients using radiotherapy, of which 63% in the United States and less than 20% in China. There are only 1.1 radiotherapy equipment per million people in China, which is 1/10 of that in the United States. China has a gap of 5 to 10 times compared with the international average in the amount of radiotherapy and diagnostic equipment. In addition, in the field of high-end medical equipment, the phenomenon of imports from medical institutions in China has been more serious. For example, nuclear magnetic resonance, CT, MI and other high-performance products are mostly imported, and imported brands account for 70% of China's high-end medical device products. In 2015, in response to the transformation and upgrading of domestic medical equipment , the policy side issued a total of 18 documents, and the national policy is paying close attention to the development of medical equipment. This year's "two sessions" coincided with the opening of the "13th Five-Year Plan". In the "13th Five-Year Plan" proposal for the pharmaceutical industry and medical and health fields, high-end medical devices were listed as one of the key breakthrough areas in the next five years. The prospect of high-end medical device investment is worth looking forward to. It is expected that high-performance medical devices such as large-scale imaging equipment and high-value medical consumables will become the focus of future policy support. With the development of computer and network technology, the informationization and networking in the medical field is the development trend of medical management in the future. This trend will lead to the growth of demand for high-tech medical equipment such as imaging and digitization. At the same time, the "Healthy China Construction Plan (2016-2020)" will become a programmatic document for promoting healthy China construction in the next five years. The relevant industries and companies in the medical and health field will usher in a rapid development opportunity, and the medical device industry will benefit significantly.
Xi'an Henrikang Biotech Co., Ltd., located in Gaoling Industrial Park, Xi`an city, Shaanxi Province, China. It is a professional supplier of Antibiotic & Antibacterial Product Raw Material,Beta Cyclodextrin Powder and natural active ingredients. It has absolute advantage because of strong research strength, modern management system and high-quality marketing team.
Antibiotic Raw,Brexanolone Chemical Raw,Eprosartan Active Ingredient,Edoxaban Antidote Powder Xi'an Henrikang Biotech Co.,Ltd , https://www.xianhenrikangbio.com
Now we have 3 GMP standard workshop, Meanwhile, the factory is equipped with the researching and quality inspection centre, with strong technology research and development strength. We also have 3 salesdepartments over 30 people and sell our products all over the world.
For customer`s needs, OEM service is also acceptable. If you have a good idea in new product production but lack of laboratory device and human resource, we are glad to solve this problem for you. Sincerely hope to strengthen exchanges and cooperation with friends from both home and abroad.